Title:
癌の治療に使用するための１６８Ａ−Ｔ２のポリペプチドフラグメントおよびそれらを含む組成物
Document Type and Number:
Japanese Patent JP6798886
Kind Code:
B2
Abstract:
The present invention relates to specific polypeptides having anti-angiogenic activity and their use for treating cancer.
Inventors:
Al-Mahomed, Salman
Colin, Sylvie
Colin, Sylvie
Application Number:
JP2016551784A
Publication Date:
December 09, 2020
Filing Date:
February 13, 2015
Export Citation:
Assignee:
Gene Signal International Society Anonymous
International Classes:
C12N15/12; A61K31/282; A61K33/24; A61K38/10; A61K38/17; A61K45/00; A61P9/00; A61P35/00; C07K14/705
Domestic Patent References:
| JP2010526549A | ||||
| JP2005530489A | ||||
| JP2012512858A |
Other References:
COLIN, S. et al.,"A TRUNCATED FORM OF CD9-PARTNER 1 (CD9P-1), GS-168AT2, POTENTLY INHIBITS IN VIVO TUMOUR-INDUCED ANGIOGENESIS AND TUMOUR GROWTH.",BRITISH JOURNAL OF CANCER,NATURE PUBLISHING GROUP,2011年 9月,Vol.105, No.7,pp.1002-1011,URL,http://dx.doi.org/10.1038/bjc.2011.303
GUILMAIN, W. et al.,"CD9P-1 EXPRESSION CORRELATES WITH THE METASTATIC STATUS OF LUNG CANCER, AND A TRUNCATED FORM OF CD9P-1, GS-168AT2, INHIBITS IN VIVO TUMOUR GROWTH.",BRITISH JOURNAL OF CANCER,NATURE PUBLISHING GROUP,2011年 2月 1日,Vol.104, No.3,pp.496-504,URL,http://dx.doi.org/10.1038/sj.bjc.6606033
GUILMAIN, W. et al.,"CD9P-1 EXPRESSION CORRELATES WITH THE METASTATIC STATUS OF LUNG CANCER, AND A TRUNCATED FORM OF CD9P-1, GS-168AT2, INHIBITS IN VIVO TUMOUR GROWTH.",BRITISH JOURNAL OF CANCER,NATURE PUBLISHING GROUP,2011年 2月 1日,Vol.104, No.3,pp.496-504,URL,http://dx.doi.org/10.1038/sj.bjc.6606033
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Kaoru Takahashi
Nao Oda
Kaoru Takahashi